ArticleJournal of clinical medicine2021

Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy.

Young-Joon Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.